glutathione adduct toxicity of the and carcinogenicity of AFB1. GSH, Glutathione Adduct Patterns of Michael-Acceptor
Description
Advanced Size Reduction Technologies: High-pressure homogenisation and microfluidisation enable the large-scale production of liposomes while maintaining a very tight, consistent particle size distribution across every batch
Electron Physician 8 (8), 27192725
In vivo studies revealed a 16.8-fold increase in plasma half-life (t) and a 16.1-fold increase in oral bioavailability compared to native GSH
Search Strategy and Study Selection : We searched MEDLINE/PubMed, Embase, Cochrane CENTRAL, and Scopus from inception to 31 July 2025
Bn cnh dng vin ung glutathione, bn cng nn chm sc ngoi da hng ngy, bo v da khi tc hi ca nh nng mt tri v n ung y dinh dng
doi: 10.3389/fnins.2025.1632905 Received 22 May 2025 Accepted 28 July 2025 Published 26 August 2025 Volume 19 - 2025 Edited by Diego A
